Real-life safety of Emtricitabine/Tenofovir Alafenamide/BictegravirNicola Squillace, Elena Ricci, Paolo Maggi et al.|PLoS ONE|2023Cited by 14
DAA-Based Treatment for HIV–HCV-Coinfected Patients: Analysis of Factors of Sustained Virological Response in a Real-Life StudyLoredana Alessio, Nicola Coppola, Vincenzo Esposito et al.|Antiviral Therapy|2019Cited by 7
Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infectionPaolo Maggi, Giuseppe Vittorio De Socio, Vincenzo Messina et al.|Expert Review of Clinical Immunology|2021Cited by 7